Skip to main content
TipRanks
Go Ultimate75% OFF

Elite Pharmaceuticals (ELTP) Ratios

378 Followers

Elite Pharmaceuticals Ratios

ELTP's free cash flow for Q2 2027 was $-3.81M. For the 2027 fiscal year, ELTP's free cash flow was decreased by $-732.18K and operating cash flow was $-3.07M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Jun 25Jun 24Mar 23Mar 22
Liquidity Ratios
Current Ratio6.454.883.072.752.82
Quick Ratio-1215.993.502.081.531.81
Cash Ratio1713.360.960.541.001.28
Solvency Ratio1.19-0.050.83369.581.04
Operating Cash Flow Ratio1365.500.63-0.250.430.97
Short-Term Operating Cash Flow Coverage103886.741.76-0.7610.7418.39
Net Current Asset Value$ 72.70M$ 14.87M$ 13.94M$ 9.57M$ 8.93M
Leverage Ratios
Debt-to-Assets Ratio0.040.110.140.100.08
Debt-to-Equity Ratio0.060.200.200.130.11
Debt-to-Capital Ratio0.060.170.170.120.10
Long-Term Debt-to-Capital Ratio0.030.050.050.110.05
Financial Leverage Ratio1.401.801.451.411.39
Debt Service Coverage Ratio64.03-0.284.54302.3815.08
Interest Coverage Ratio125.9525.3818.331819.9926.44
Debt to Market Cap0.010.020.050.130.05
Interest Debt Per Share0.010.010.010.000.00
Net Debt to EBITDA-573.16-0.141.84-0.61-0.89
Profitability Margins
Gross Profit Margin49.36%47.70%46.55%48.58%45.86%
EBIT Margin33.56%0.86%1.86%0.01%15.72%
EBITDA Margin34.92%3.38%4.46%0.02%20.12%
Operating Profit Margin33.56%23.32%19.05%5.93%15.72%
Pretax Profit Margin38.16%-0.06%0.82%11.67%22.20%
Net Profit Margin30.14%-5.13%35.51%12.91%27.58%
Continuous Operations Profit Margin30.14%-5.13%35.51%0.01%27.58%
Net Income Per EBT78.98%8275.14%4342.25%110.64%124.25%
EBT Per EBIT113.72%-0.27%4.29%196.82%141.24%
Return on Assets (ROA)32.45%-4.48%24.04%10783.21%25.32%
Return on Equity (ROE)45.38%-8.06%34.92%15227.43%35.28%
Return on Capital Employed (ROCE)41.32%23.18%15.28%6125.12%17.82%
Return on Invested Capital (ROIC)32.33%21.87%14.27%6065.36%17.48%
Return on Tangible Assets-0.96%-4.75%26.01%12762.06%31.21%
Earnings Yield11.54%-0.93%12.94%15012.72%25.19%
Efficiency Ratios
Receivables Turnover2.492.882.9111037.1910.55
Payables Turnover12.4514.8611.157177.1412.21
Inventory Turnover0.002.712.341838.722.59
Fixed Asset Turnover0.015.963.883271.814.62
Asset Turnover1.080.870.68835.170.92
Working Capital Turnover Ratio2.122.312.792643.203.48
Cash Conversion Cycle103041.71237.14248.590.18145.56
Days of Sales Outstanding146.41126.85125.390.0334.60
Days of Inventory Outstanding102924.61134.85155.930.20140.87
Days of Payables Outstanding29.3124.5632.730.0529.90
Operating Cycle103071.02261.70281.320.23175.47
Cash Flow Ratios
Operating Cash Flow Per Share22.140.01-0.000.000.01
Free Cash Flow Per Share21.270.00-0.00-0.000.01
Dividend Paid and CapEx Coverage Ratio25.662.95-4.050.5813.05
Capital Expenditure Coverage Ratio25.662.95-4.050.5813.05
Operating Cash Flow Coverage Ratio4083.510.68-0.280.862.34
Operating Cash Flow to Sales Ratio159.520.09-0.060.000.20
Free Cash Flow Yield5870.03%1.06%-2.63%-8.16%17.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio8.67-108.757.730.013.97
Price-to-Sales (P/S) Ratio2.615.532.740.001.09
Price-to-Book (P/B) Ratio3.938.682.701.011.40
Price-to-Free Cash Flow (P/FCF) Ratio0.0294.25-37.97-12.255.88
Price-to-Operating Cash Flow Ratio0.0262.33-47.348.805.43
Price-to-Earnings Growth (PEG) Ratio-0.010.90-0.080.000.06
Enterprise Value Multiple-565.68163.3463.413.964.55
Enterprise Value-29.40B464.31M159.99M25.43M29.57M
EV to EBITDA-565.68163.3463.413.964.55
EV to Sales-197.515.522.830.000.92
EV to Free Cash Flow-1.2994.17-39.11-10.604.92
EV to Operating Cash Flow-1.2462.28-48.767.624.54
Tangible Book Value Per Share-4.370.040.050.020.02
Shareholders’ Equity Per Share0.090.050.060.030.02
Tax and Other Ratios
Effective Tax Rate0.21-81.75-42.42-0.11-0.24
Revenue Per Share0.140.080.0633.720.03
Net Income Per Share0.04-0.000.024.350.01
Tax Burden0.7982.7543.421.111.24
Interest Burden1.14-0.070.44781.761.41
Research & Development to Revenue38.580.090.120.180.13
SG&A to Revenue118.200.110.120.150.14
Stock-Based Compensation to Revenue1.190.000.150.000.02
Income Quality0.53-1.73-0.160.940.73

Currency in USD